0001610618-23-000032.txt : 20230329
0001610618-23-000032.hdr.sgml : 20230329
20230329172826
ACCESSION NUMBER: 0001610618-23-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230327
FILED AS OF DATE: 20230329
DATE AS OF CHANGE: 20230329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandison Taylor
CENTRAL INDEX KEY: 0001702287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 23776297
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
wf-form4_168012529430238.xml
FORM 4
X0407
4
2023-03-27
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001702287
Sandison Taylor
C/O CIDARA THERAPEUTICS, INC.
6310 NANCY RIDGE DR, STE 101
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-03-27
4
A
0
90000
0
A
378550
D
Employee Stock Option (right to buy)
1.01
2023-03-27
4
A
0
180000
0
A
2033-03-26
Common Stock
180000.0
180000
D
Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.
/s/ Shane Ward, Attorney-in-Fact
2023-03-29